REGN•benzinga•
Unity Biotechnology Unveils Mixed Data From Study For Diabetes-Related Blindness, Stock Falls
Summary
Unity diabetes study showing durable vision gains with full 36-week data expected in Q2 2025.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 24, 2025 by benzinga